You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Exercise Disclosure
Janku Filip · SEC Form 4 · Filed Jun 30, 2026
Exercise
Calculated transaction value
$45.36K
Janku Filip Chief Medical Officer
GLUE
Transaction date
Jun 29, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$23.9
Jun 29, 2026
First close after public filing
$24.02
Jul 1, 2026
30-day return after filing
-5.58%
Through Jul 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,000 shares @ $7.56
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-290486
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$183.06K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE Current | Exercise | Jun 29, 2026 | $45.36K |
| Monte Rosa Therapeutics, Inc. GLUE | Sale | Jun 29, 2026 | $137.7K |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 29, 2026 | $0 |